{
    "2019-12-11": [
        [
            {
                "time": "",
                "original_text": "金域医学：君睿祺减持30万股，持股比降至4.9993% 减持股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "君睿祺",
                        "减持",
                        "30万股",
                        "持股比",
                        "4.9993%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "金域医学(603882.SH)：君睿祺和君联茂林合计持股降至6.2993%",
                "features": {
                    "keywords": [
                        "金域医学",
                        "君睿祺",
                        "君联茂林",
                        "合计持股",
                        "6.2993%"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}